Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)

Clinical trial NCT03305133 · COMPLETED

Trial details

NCT number: NCT03305133
Sponsor: Groupe Francais De Pneumo-Cancerologie
Status: COMPLETED
Study type: OBSERVATIONAL

Large Cell Lung Cancer Neuroendocrine Carcinoma of Lung (Diagnosis)

Start date: 2017-09-26
Primary completion: 2018-09-14
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.